United States In Vitro Diagnostics Tests Markets Report 2021: Notable Corporate Events and Developments from 2018, 2019 and 2020 - Forecasts to 2025

News provided by

Jul 20, 2021, 16:15 ET

DUBLIN, July 20, 2021 /PRNewswire/ -- The "United States Market for In Vitro Diagnostics Tests" report has been added to ResearchAndMarkets.com's offering.

The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world.

COVID-19 had a profound effect on the IVD diagnostic industry - some segments exploded and others languished. At this point in time, it is hard to predict how the coronavirus will impact the forecast years to 2025, but the analyst has attempted to provide insight into the industry by conversing with market participants and government entities.

It is realistic to assume the market for COVID-19 will remain a component of the IVD market as the continued prevalence of the virus and the evolving variants are expected to remain. It should be noted that the market can be uncertain and ongoing research will help determine the long-term path of the segment in the coming months to years.

Demographic aging is also one of the primary market influencing trends for IVD in the United States. Aging is associated with rising incidences and rates of prevalence for several non-infectious diseases including diabetes and cancer. Individuals over the age of 60 are estimated to average at least four times the number of clinical tests of younger individuals.

This latest report, United States Market for In Vitro Diagnostic Tests, discusses these and other trends shaping the present and future of the IVD market in America.

The report discusses the following IVD market segments in the United States:

Clinical Chemistry
Microbiology (Traditional) - Identification and Antibiotic Susceptibility Testing (ID/AST)
Microbiology - Molecular - Infectious Disease
Point-of-Care (POC) Tests - Diabetes
Point-of-Care (POC) Tests - All Other
Immunoassays - Infectious Disease (non-POC)
Immunoassays - Other
Molecular - Non-infectious Disease
Hematology
Coagulation (non-POC)
Histology
Blood Testing and Typing
Others

In addition, the report profiles the top players in the U.S. IVD market. The profiles cover notable corporate events and developments from 2018, 2019 and 2020.

Featured companies include:

Abbott Diagnostics
Beckman Coulter, Inc./Danaher
Becton, Dickinson and Company (Bd)
Biomerieux
Bio-Rad Laboratories, Inc.
Cepheid/Danaher
Danaher Corporation
Hologic, Inc.
Ortho Clinical Diagnostics (Ortho)
Qiagen N.V.
Roche Diagnostics
Siemens Healthineers (Siemens)
Sysmex Corporation
Thermo Fisher Scientific Inc.

Key Topics Covered:

Chapter 1: Executive Summary

U.S. IVD Market
Top Tier U.S. IVD Market Participants and Rankings
Conclusions

Chapter 2: Introduction to U.S. Health Care

The United States and In Vitro Diagnostics
U.S. Patient Population
Healthcare System Utilization
Aging
Disease Prevalence and Incidence
U.S. Clinical Lab Expenditure
Hospital-Acquired Infections (HAIs)
Preventive Health Care
Product Innovation from Value-Based Pricing
Clinical Testing under Medicare - Reimbursement Cuts and Market-Based Pricing
Protecting Access to Medicare Act of 2014 (PAMA)
Impact of CARES Act on PAMA
Personalized Medicine and NGS
Laboratory-Developed Tests (LDTs)
Changes Resulting from COVID-19 Pandemic
U.S. Healthcare Infrastructure and Testing Channels
Hospitals
Independent Labs
Physician Office Laboratories
Self-Testing
Retail Clinics
Conclusions

Chapter 3: U.S. IVD Market Analysis

Clinical Chemistry
Microbiology and Virology - ID/AST and Molecular
Molecular Infectious Disease
Point-of-Care Testing
Immunoassays
Non-Infectious Disease Immunoassay
Infectious Disease Immunoassay
Molecular Non-Infectious Disease Diagnostics
Coagulation
Histology
Hematology
Blood Testing and Typing
Total U.S. IVD Market

Chapter 4: Top Tier U.S. IVD Market Players

Abbott Diagnostics
Beckman Coulter, Inc./Danaher
Beckman Coulter Life Sciences
bioMerieux
BIOFIRE Diagnostics Business
Bio-Rad Laboratories, Inc.
GeneXpert Xpress Line
Danaher Corporation
Hologic, Inc.
PANTHER Molecular System
QIAGEN N.V.
Roche Diagnostics
Siemens Healthineers (Siemens)
Sysmex Corporation
Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/tkxe1l

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets